Stanford School of Medicine
Child and Adolescent Psychiatry

Emmanuel Mignot

Profile: http://med.stanford.edu/profiles/Emmanuel_Mignot/

Contact:
Name: Kelly Stover
Title: Assistant
Email: kstover@stanford.edu
Phone: 650-725-6517

Academic Appointments
Appointment
Organization
Professor
Member
 
Web Site Links
Research Interests

Research interests focus on mechanisms underlying disorders of excessive sleepiness, neurochemical mechanisms of arousal state control, and the genetics of sleep disorders with emphasis on Narcolepsy.

Clinical studies are mostly aimed at better defining the symptoms of narcolepsy (sleepiness, cataplexy, sleep paralysis, hypnagogic hallucinations and disrupted nocturnal sleep) using questionnnaire based evaluations and sleep recording studies. Blood samples are also collected for human genetic studies. Clinical and genetic data is entered in a database containing more than 500 narcoleptic subjects (family members and control subjects not included). Functional immaging studies are performed in human narcoleptic patients during cataplexy. Genomic studies are performed to identify susceptibility factors. CSF analysis in various clincial subgroups is performed to measure hypocretin levels.

Pharmacological studies are performed in both human narcoleptic patients and in a canine model. Clinical trials are routinely conducted. Canine pharmacology experiments have led to the pharmacological dissection of the mode of action of antidepressants and amphetamine-like stimulants in narcolepsy. EEG analysis, in vivo dialysis, single unit recording and local drug injections are also being performed to identify the neurobiological substatum underlying sleep abnormalities in narcolepsy. Critical neurochemical systems such as the hypothalamic hypocretin/orexin system, the mesolimbic dopaminergic systems and pontine cholinergic systems have also been identified and are being intensively studied.

Genetic and genomic studies are being performed in both humans and dogs. A positional cloning project identified the hypocretin (orexin) receptor 2 mutation as the canine narcolepsy gene. Mutation screening in hypocretin peptide and receptor genes is being performed in human and canine narcolepsy. Functional studies are carried out to study the effect of any potential mutation. HLA typing studies are performed to refine HLA assocaition modeling in narcolepsy. Other studies are aiming at demonstrating a possible autoimmune abnormality affecting the hypocretin system in human narcolepsy.

Publications
  • Mignot E, Takahashi JS "A circadian sleep disorder reveals a complex clock." Cell 2007; 128: 1: 22-3 More »
  • Friedman LF, Zeitzer JM, Lin L, Hoff D, Mignot E, Peskind ER, Yesavage JA "In Alzheimer disease, increased wake fragmentation found in those with lower hypocretin-1." Neurology 2007; 68: 10: 793-4 More »
  • Renier C, Faraco JH, Bourgin P, Motley T, Bonaventure P, Rosa F, Mignot E "Genomic and functional conservation of sedative-hypnotic targets in the zebrafish." Pharmacogenet Genomics 2007; 17: 4: 237-53 More »
  • Mignot E, "A step forward for restless legs syndrome." Nat Genet 2007; 39: 8: 938-9 More »
  • Zhang S, Zeitzer JM, Sakurai T, Nishino S, Mignot E "Sleep/wake fragmentation disrupts metabolism in a mouse model of narcolepsy." J Physiol 2007; More »
134 publications:   view full list

Footer Links: